Yew Bio-Pharm Group, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was USD 27.883 million compared to USD 37.596 million a year ago. Operating income was USD 1.011 million compared to USD 718,597 a year ago. Net income was USD 985,506 compared to net loss of USD 1.322 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.03 a year ago.